Produktbild: Clinical Xenotransplantation

Clinical Xenotransplantation Pathways and Progress in the Transplantation of Organs and Tissues Between Species

145,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

09.09.2020

Abbildungen

XXIX, 306 p. 82 illus., 59 illus. in color.

Herausgeber

David K. C. Cooper + weitere

Verlag

Springer

Seitenzahl

306

Maße (L/B/H)

24,1/16/2,3 cm

Gewicht

731 g

Auflage

20001 Auflage 1st edition 2020

Sprache

Englisch

ISBN

978-3-030-49126-0

Beschreibung

Portrait


David K.C. Cooper MD, PhD, FRCSUniversity of Alabama at Birmingham (UAB)Co-Director, Xenotransplantation ProgramDepartment of SurgeryBirmingham, AL 



Guerard W. Byrne, PhDDepartment of SurgeryUniversity of Alabama at BirminghamBirmingham, ALUSA



Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

09.09.2020

Abbildungen

XXIX, 306 p. 82 illus., 59 illus. in color.

Herausgeber

Verlag

Springer

Seitenzahl

306

Maße (L/B/H)

24,1/16/2,3 cm

Gewicht

731 g

Auflage

20001 Auflage 1st edition 2020

Sprache

Englisch

ISBN

978-3-030-49126-0

Herstelleradresse

Springer-Verlag KG
Sachsenplatz 4-6
1201 Wien
AT

Email: ProductSafety@springernature.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Clinical Xenotransplantation
  • Clinical and Experimental Xenotransplantation: Background.- 1. A brief history of clinical cross-species organ xenotransplantation.- 2. The pathobiology of pig-to-primate xenotransplantation: a historical review.- 3. Is sensitization to pig antigens detrimental to subsequent allotransplantation?.- 4. Sensitization to human leukocyte antigens and xenotransplantation?.- Pig Kidney and Heart Xenotransplantation in Nonhuman Primates – the Present Position.- 5. Kidney xenotransplantation in nonhuman primates.- 6. Cardiac xenotransplantation in nonhuman primates.- Organ-source Pig Genetic Engineering and Regulation.- 7. Gene-edited pigs for xenotransplantation.- 8. Addressing regulatory requirements for the organ-source pig – a pragmatic approach to facility design and pathogen prevention.- Antibody-Mediated Allotransplant Rejection: Lessons for Xenotransplantation.- 9. Antibody-mediated graft rejection in nonhuman primate models: comparison of sensitized allotransplant and xenotransplant rejection.- 10. Management of anti-HLA antibodies and acute antibody-mediated rejection.- 11. Evolving approaches to treatment of allosensitization and antibody-mediated rejection.- 12. Lessons from ABO-incompatible cardiac allotransplantation in the newborn.- Patient Evaluation and Selection for First Clinical Trials of Kidney or Heart Xenotransplantation.- 13. Defining an “acceptable risk threshold” – who should be the first kidney xenotransplant recipient?.- 14. Selection of patients for initial clinical trials of kidney xenotransplantation.- 15. Selection of patients for initial clinical trials of cardiac xenotransplantation.- 16. Selection of pediatric patients for initial clinical trials of cardiac xenotransplantation.- 17. Infection in xenotransplantation: organ-source health and patient safety.- 18. Histocompatibility testing for xenotransplantation.- Regulatory, Economic, and Social Aspects of Clinical Trials of Xenotransplantation.- 19. Xenotransplantation; the FDA perspective.- 20. Xenotransplantation: a payer’s perspective.- 21. Public perceptions towards clinical trials of organ xenotransplantation.- Summation.- 22. What did the workshop achieve?